We’re pleased to announce All.Can International’s new Board of Directors, further to their election and endorsement at All.Can’s Annual General Meeting (AGM) held on Monday, 12 May.
Matti Aapro, who has been president of All.Can since 2023, takes on the position of Immediate Past President and remains on the Board of Directors. We extend our heartfelt thanks to Matti, whose leadership as outgoing President helped steer the organisation through key milestones during a time of growth and impact.
We’re delighted to welcome Professor Christobel Saunders as the new President of All.Can International. A globally recognized oncologist and researcher, Christobel brings decades of experience and a strong commitment to patient-centred innovation in cancer care.
After 5 years as All.Can’s first President and more recently as Past President, Alex Filicevas is stepping down from the Board of Directors. His tireless dedication to advancing efficiency, equity and patient voice in cancer care has left a legacy that will continue to guide our work for years to come. Professor Tit Albreht is also stepping down as a Director. Both will continue to be represented as All.Can members – Alex through the World Bladder Cancer Patient Coalition’s organisational membership and Tit as an individual member.
All.Can’s Board of Directors 2025-2027
- Christobel Saunders, University of Melbourne, All.Can President
- Bettina Borisch, Institute of Global Health, University of Geneva, All.Can Vice President
- Matti Aapro, Clinique de Genolier, Switzerland, All.Can Immediate Past President
- Ebba Hallersjo Hult, Vision Zero Cancer
- Matt Hickey, Health Value Alliance
- George Kapetanakis, ELLOK
- Darien Laird, Global Coalition for Radiotherapy
- Chaira Morini, BMS
- Michael Oberreiter, Roche
- Eduardo Pisani, CEO and Ex Officio Board Member
We look forward to the future of All.Can under the guidance and leadership of its new board.